Sharon Bio-Medicine has informed that the Meeting of the Board of Directors of the Company is scheduled to be held on August 29, 2015 to consider adoption of Audited Financial Result for the Quarter and Year ended as on June 30, 2015. Further in terms of Code of conduct adopted by the Company under SEBI (Prohibition of insider Trading) Regulations, 2015. The trading window will be closed for the adoption of Financial Results. Date: August 29, 2015. Window closure period: August 27, 2015 to September 01, 2015. The trading window will open on September 02, 2015.
The above information is a part of company’s filings submitted to BSE.
